3692.HK 财务： Hansoh Pharmaceutical Group Company Limited AI 分析

Q: 技术分析指标如何适用于 3692.HK？

根据技术分析，Hansoh Pharmaceutical Group Company Limited 的综合信号为 Buy。Hansoh Pharmaceutical Group Company Limited 有 4 个买入信号，0 个中性信号和 3 个卖出信号。

Q: 3692.HK 的斐波那契回调水平是多少？

Hansoh Pharmaceutical Group Company Limited 的斐波那契回调水平是 在 78.6% 和 100% 之间。

Q: Hansoh Pharmaceutical Group Company Limited 的 RSI 是多少？

Hansoh Pharmaceutical Group Company Limited 的 RSI 目前为 75.98，表明处于 超买 状态

Q: Hansoh Pharmaceutical Group Company Limited 接下来 12 个月的价格是多少？

Hansoh Pharmaceutical Group Company Limited 3692.HK 接下来 12 个月的价格预计为 $45.22。

Q: Hansoh Pharmaceutical Group Company Limited 预计会涨到多高？

据华尔街分析师称，Hansoh Pharmaceutical Group Company Limited 预计将达到 $52.5 的高预测值。

主页

股票

3692.HK

预测

HANSOH PHARMA (3692.HK)

Hansoh Pharmaceutical Group Company Limited

HK$43

-0.18%

$-0.07

休市： Jan 16, 16:00:00 HKT

360

报告

A+

最终得分

关键数据

前收盘价

$43.12

开盘价

$43.08

当日区间

$42.3 - $43.08

52周范围

$16.7 - $44.22

交易量

3.7M

平均成交量

8.3M

每股收益（TTM）

0.89

股息收益率

市值

$255.6B

什么是 HANSOH PHARMA？

Hansoh Pharmaceutical Group Co., Ltd. is a holding company, which engages in the research and development, production, and sale of a series of pharmaceutical products. The company is headquartered in Shanghai, Shanghai and currently employs 9,313 full-time employees. The company went IPO on 2019-06-14. The Company’s innovative drug products include Ameile, Hansoh Xinfu, Mailingda, Fulaimei, Hengmu, XINYUE, Saint Luolai and other products. The Company’s drug products are mainly used in oncology, anti-infective diseases, central nervous system (CNS) diseases, metabolic diseases and other therapeutic areas. The firm mainly conducts its business in the domestic market.

功能特性

交易策略

资源

市场

Utilizing our sophisticated predictive model, we anticipate notable price fluctuations for 3692.HK in the upcoming periods. Looking toward the future, our 2027 projection indicates an average price target of $45.22. The lowest target is $35.85 and the highest is $52.5. Empower your investment choices with our cutting-edge, data-driven analysis!

3692.HK 股价预测摘要

3692.HK的顶级分析师评级

基于 30 位分析师对 3692.HK 的股票评级，更新于 Jan 01, 2026

Strong Buy

Strong buy

Buy

Hold

Sell

Strong sell

Leveraging in-depth analyst evaluations, we have synthesized critical insights from expert assessments to deliver a robust outlook for 3692.HK. Our analysts highlight strong fundamentals and favorable market sentiment, positioning 3692.HK for significant upside potential in the near term. Based on this comprehensive expert analysis, we maintain a highly optimistic view of this stock. Our conclusion: 3692.HK is a Strong Buy candidate.

3692.HK stock price ended at $43.12 on 星期四, after rising 0.42%

On the latest trading day Jan 15, 2026, the stock price of 3692.HK rose by 0.42%, climbing from $44.22 to $43.12. Throughout the session, the stock experienced a volatility of 4.64%, with prices fluctuating between a daily low of $42.26 and a high of $44.22. Alongside this price increase, trading volume also rose by 3.7M shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 6.3M shares were traded, amounting to a market value of approximately $256.3B.

3692.HK 技术面信号

技术面信号摘要

购买信号 4

中性信号 0

卖出信号 3

Strong Sell

Sell

Neutral

Buy

Strong Buy

3692.HK目前显示4个买入信号和3个卖出信号。该股票自12:00 AM以来一直处于上升趋势状态，在此期间价格总变动为6.1%。总体而言，技术指标显示中期前景为Buy。

3692.HK 的看涨/看跌信号

我们的算法通过分析移动平均线、RSI、MACD 和成交量等关键指标，为 3692.HK 生成看涨和看跌信号。这些见解可助您做出明智的投资决策。

后续问题

技术分析指标如何适用于 3692.HK？



3692.HK 的斐波那契回调水平是多少？



Hansoh Pharmaceutical Group Company Limited 的 RSI 是多少？



Hansoh Pharmaceutical Group Company Limited 接下来 12 个月的价格是多少？



Hansoh Pharmaceutical Group Company Limited 预计会涨到多高？



Hansoh Pharmaceutical Group Company Limited（3692.HK）价格

3692.HK 股价走势图